PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 268 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 3.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $100,293 | +175.0% | 3,269 | +259.2% | 0.02% | +100.0% |
| Q2 2023 | $36,464 | +26.6% | 910 | +28.9% | 0.01% | +22.2% |
| Q1 2023 | $28,812 | +22.9% | 706 | +16.3% | 0.01% | +12.5% |
| Q4 2022 | $23,436 | -82.8% | 607 | -76.2% | 0.01% | -88.1% |
| Q3 2022 | $136,000 | +20.4% | 2,547 | +31.6% | 0.07% | -4.3% |
| Q2 2022 | $113,000 | -38.6% | 1,935 | -19.7% | 0.07% | -23.9% |
| Q1 2022 | $184,000 | +32.4% | 2,411 | +4.3% | 0.09% | +41.5% |
| Q4 2021 | $139,000 | +17.8% | 2,312 | +9.9% | 0.06% | -14.5% |
| Q3 2021 | $118,000 | +12.4% | 2,103 | +21.8% | 0.08% | +15.2% |
| Q2 2021 | $105,000 | – | 1,727 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Key Colony Management, LLC | 134,600 | $13,045,000 | 11.31% |
| Biondo Investment Advisors, LLC | 279,717 | $27,110,000 | 8.33% |
| GILDER GAGNON HOWE & CO LLC | 3,177,130 | $307,927,000 | 4.48% |
| DARUMA CAPITAL MANAGEMENT LLC | 814,470 | $78,938,000 | 3.47% |
| MAGEE THOMSON INVESTMENT PARTNERS LLC | 126,022 | $12,214,000 | 3.01% |
| NEXT CENTURY GROWTH INVESTORS LLC | 768,396 | $74,472,000 | 2.63% |
| MARXE AUSTIN W & GREENHOUSE DAVID M | 180,000 | $17,446,000 | 2.38% |
| Lisanti Capital Growth, LLC | 48,280 | $4,679,000 | 2.35% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 79,017 | $7,658,000 | 2.00% |
| Atika Capital Management LLC | 21,500 | $2,084,000 | 1.60% |